Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients

Kristian Hellenkamp(German Centre for Cardiovascular Research), Marco R. Schroeter(Universitätsmedizin Göttingen), Yannick D. Gabriel(German Centre for Cardiovascular Research), Claudius Jacobshagen(University of Göttingen), Alexander Becker(Robert Bosch Hospital), Gerd Hasenfuß(Universitätsmedizin Göttingen), Wolfgang Schillinger, Mark Hünlich(University of Göttingen)
International Journal of Cardiology
February 22, 2017
10.1016/j.ijcard.2017.02.069
Cited by 5

Related Papers

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.
|Circulation Research|1994|776
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
|The Lancet|2017|588
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258
17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells
|The FASEB Journal|2001|226
Enhanced Detection of Paroxysmal Atrial Fibrillation by Early and Prolonged Continuous Holter Monitoring in Patients With Cerebral Ischemia Presenting in Sinus Rhythm
|Stroke|2010|222